← All Sponsors
SPONSOR

Dong-A ST Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Locally Advanced or Metastatic Solid Tumors
NCT06293651 Phase 1, Phase 2
Recruiting

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors
South Korea View Trial →